Search Results - "Gospodarowicz, Mary K."

Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities , 3rd edition by Gelband, Hellen, MHS, Sankaranarayanan, Rengaswamy, MD, Gauvreau, Cindy L, PhD, Horton, Susan, Prof, Anderson, Benjamin O, MD, Bray, Freddie, DPhil, Cleary, James, MD, Dare, Anna J, PhD, Denny, Lynette, MD, Gospodarowicz, Mary K, MD, Gupta, Sumit, MD, Howard, Scott C, Prof, Jaffray, David A, PhD, Knaul, Felicia, PhD, Levin, Carol, PhD, Rabeneck, Linda, MD, Rajaraman, Preetha, PhD, Sullivan, Terrence, PhD, Trimble, Edward L, MD, Jha, Prabhat, Prof

“…Summary Investments in cancer control—prevention, detection, diagnosis, surgery, other treatment, and palliative care—are increasingly needed in low-income and…”
Get full text

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial by VITOLO, Umberto, CHIAPPELLA, Annalisa, MARTINELLI, Giovanni, MERLI, Francesco, NOVERO, Domenico, ORSUCCI, Lorella, PAVONE, Vincenzo, RICARDI, Umberto, STORTI, Sergio, GOSPODAROWICZ, Mary K, CAVALLI, Franco, SARRIS, Andreas H, FERRERI, Andrés J. M, ZUCCA, Emanuele, MARTELLI, Maurizio, BALDI, Ileana, BALZAROTTI, Monica, BOTTELLI, Chiara, CONCONI, Annarita, GOMEZ, Henry, LOPEZ-GUILLERMO, Armando

“…Primary testicular lymphoma (PTL) has poor prognosis with failures in contralateral testis, CNS, and extranodal sites. To prevent these events, we designed an…”
Get full text

Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital’s Experience by Sturgeon, Jeremy F, Moore, Malcolm J, Kakiashvili, David M, Duran, Ignacio, Anson-Cartwright, Lynn C, Berthold, Dominik R, Warde, Padraig R, Gospodarowicz, Mary K, Alison, Ruth E, Liu, Justin, Ma, Clement, Pond, Greg R, Jewett, Michael A

“…Abstract Background Since 1981 Princess Margaret Hospital has used initial active surveillance (AS) with delayed treatment at relapse as the preferred…”
Get full text

Localized Orbital Mucosa-Associated Lymphoma Tissue Lymphoma Managed With Primary Radiation Therapy: Efficacy and Toxicity by Goda, Jayant Sastri, M.D, Le, Lisa W., M.Sc, Lapperriere, Normand J., M.D, Millar, Barbara-Ann, M.B., Ch.B, Payne, David, M.D, Gospodarowicz, Mary K., M.D, Wells, Woodrow, M.D, Hodgson, David C., M.D, Sun, Alexander, M.D, Simpson, Rand, M.D, Tsang, Richard W., M.D

“…Purpose To evaluate the clinical outcomes and late effects of radiation therapy (RT) in localized primary orbital mucosa-associated lymphoma tissue (MALT)…”
Get full text

Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome by TSANG, Richard W, GOSPODAROWICZ, Mary K, PINTILIE, Melania, WELLS, Woodrow, HODGSON, David C, SUN, Alexander, CRUMP, Michael, PATTERSON, Bruce J

“…Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is a distinct lymphoma with unique clinicopathologic features. We…”
Get full text

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group by MEYER, Ralph M, GOSPODAROWICZ, Mary K, DJURFELDT, Marina S, KEYUE DING, SHEPHERD, Lois E, CONNORS, Joseph M, PEARCEY, Robert G, BEZJAK, Andrea, WELLS, Woodrow A, BURNS, Bruce F, WINTER, Jane N, HORNING, Sandra J, DAR, A. Rashid

“…We report results of a randomized trial comparing ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy alone with treatment that includes…”
Get full text

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy by CROOK, Juanita M, O'CALLAGHAN, Christopher J, WARDE, Padraig, CORBETT, Thomas, ANGYALFI, Steve, GOLDENBERG, S. Larry, GOSPODAROWICZ, Mary K, SAAD, Fred, LOGUE, John P, HALL, Emma, SCHELLHAMMER, Paul F, DING, Keyue, DUNCAN, Graeme, KLOTZ, Laurence, DEARNALEY, David P, HIGANO, Celestia S, HORWITZ, Eric M, FRYMIRE, Eliot, MALONE, Shawn, CHIN, Joseph, NABID, Abdenour

Get full text

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue by Zucca, Emanuele, Conconi, Annarita, Pedrinis, Ennio, Cortelazzo, Sergio, Motta, Teresio, Gospodarowicz, Mary K., Patterson, Bruce J., Ferreri, Andrés JM, Ponzoni, Maurilio, Devizzi, Liliana, Giardini, Roberto, Pinotti, Graziella, Capella, Carlo, Zinzani, Pier Luigi, Pileri, Stefano, López-Guillermo, Armando, Campo, Elias, Ambrosetti, Achille, Baldini, Luca, Cavalli, Franco

“…A retrospective survey of patients with pathologically reviewed extragastric mucosa-associated lymphoma tissue (MALT) lymphomas from 20 institutions was…”
Get full text

Role of Salvage Radiation Therapy for Patients With Relapsed or Refractory Hodgkin Lymphoma Who Failed Autologous Stem Cell Transplant by Goda, Jayant S., MD, Massey, Christine, MSc, Kuruvilla, John, MD, Gospodarowicz, Mary K., MD, Wells, Woodrow, MD, Hodgson, David C., MD, Sun, Alexander, MD, Keating, Armand, MD, Crump, Michael, MD, Tsang, Richard W., MD

“…Purpose To analyze, through chart review, the efficacy of salvage radiation therapy (sRT) for relapsed or progressive Hodgkin lymphoma (HL) patients who failed…”
Get full text

A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma by Lee, Justin, Hodgson, David, Chow, Edward, Bezjak, Andrea, Catton, Pamela, Tsuji, Debbie, O'Brien, Mary, Danjoux, Cyril, Hayter, Charles, Warde, Padraig, Gospodarowicz, Mary K.

“…BACKGROUND Renal cell carcinoma (RCC) has previously been described as being less responsive to radiotherapy (RT) than other tumor types. The authors conducted…”
Get full text

Long-term outcome of radiation-based conservation therapy for invasive bladder cancer by Chung, Peter W.M., M.B, Bristow, Robert G., M.D, Milosevic, Michael F., M.D, Yi, Qi-long, M.Sc, Jewett, Michael A.S., M.D, Warde, Padraig R., M.B, Catton, Charles N., M.D, McLean, Michael, M.B, Moore, Malcolm, M.D, Tannock, Ian F., M.D, Gospodarowicz, Mary K., M.D

“…Abstract Purpose To report the long-term results and examine factors associated with bladder preservation, risk of relapse, and survival in patients treated…”
Get full text

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy by Crook, Juanita M, O'Callaghan, Christopher J, Duncan, Graeme, Dearnaley, David P, Higano, Celestia S, Horwitz, Eric M, Frymire, Eliot, Malone, Shawn, Chin, Joseph, Nabid, Abdenour, Warde, Padraig, Corbett, Thomas, Angyalfi, Steve, Goldenberg, S. Larry, Gospodarowicz, Mary K, Saad, Fred, Logue, John P, Hall, Emma, Schellhammer, Paul F, Ding, Keyue, Klotz, Laurence

“…Androgen-deprivation therapy for prostate cancer has side effects. In this study, intermittent androgen-deprivation therapy was associated with a survival rate…”
Get full text

Radiation therapy for localized low-grade non-Hodgkin's lymphomas by Tsang, Richard W., Gospodarowicz, Mary K.

“…The most common low grade B‐cell non‐Hodgkin's lymphomas are follicular lymphomas, and extranodal marginal zone lymphomas, also known as mucosa‐associated…”
Get full text

Low-Grade Non-Hodgkin Lymphomas by Tsang, Richard W., MD, FRCPC, Gospodarowicz, Mary K., MD, FRCPC, FRCR (Hon)

“…The most common low-grade non-Hodgkin lymphomas are of B-cell origin. This review will focus on follicular lymphomas and extranodal marginal zone lymphomas,…”
Get full text

ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma by Meyer, Ralph M, Gospodarowicz, Mary K, Connors, Joseph M, Pearcey, Robert G, Wells, Woodrow A, Winter, Jane N, Horning, Sandra J, Dar, A. Rashid, Shustik, Chaim, Stewart, Douglas A, Crump, Michael, Djurfeldt, Marina S, Chen, Bingshu E, Shepherd, Lois E

“…In patients with limited-stage Hodgkin's disease, ABVD chemotherapy alone resulted in a higher rate of long-term (12-year) survival than either radiation…”
Get full text

Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions by Gospodarowicz, Mary K, Jaffray, David A, Knaul, Felicia M

“…The Lancet Oncology was launched 20 years ago with a mission to bridge the divide between science and clinical practice, and to address the enormous global…”
Get full text

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy by Hamilton, Robert J., Ding, Keyue, Crook, Juanita M., O’Callaghan, Christopher J., Higano, Celestia S., Dearnaley, David P., Horwitz, Eric M., Goldenberg, S. Larry, Gospodarowicz, Mary K., Klotz, Laurence

“…Studies have conflicting results regarding the association between statin use and biochemical recurrence for prostate cancer (PCa). A limited number of studies…”
Get full text

Enhancing Career Paths for Tomorrow's Radiation Oncologists by Vapiwala, Neha, Thomas, Charles R., Grover, Surbhi, Yap, Mei Ling, Mitin, Timur, Shulman, Lawrence N., Gospodarowicz, Mary K., Longo, John, Petereit, Daniel G., Ennis, Ronald D., Hayman, James A., Rodin, Danielle, Buchsbaum, Jeffrey C., Vikram, Bhadrasain, Abdel-Wahab, May, Epstein, Alan H., Okunieff, Paul, Goldwein, Joel, Kupelian, Patrick, Weidhaas, Joanne B., Tucker, Margaret A., Boice, John D., Fuller, Clifton David, Thompson, Reid F., Trister, Andrew D., Formenti, Silvia C., Barcellos-Hoff, Mary-Helen, Jones, Joshua, Dharmarajan, Kavita V., Zietman, Anthony L., Coleman, C. Norman

Get full text

Cancer in the world: a call for international collaboration by Gospodarowicz, Mary K, Cazap, Eduardo, Jadad, Alex R

Get full text

PMH 9907: Long‐term outcomes of a randomized phase 3 study of short‐term bicalutamide hormone therapy and dose‐escalated external‐beam radiation therapy for localized prostate cancer by McPartlin, Andrew J., Glicksman, Rachel, Pintilie, Melania, Tsuji, Debbie, Mok, Gary, Bayley, Andrew, Chung, Peter, Bristow, Robert G., Gospodarowicz, Mary K., Catton, Charles N., Milosevic, Michael, Warde, Padraig R.

“…BACKGROUND The role of hormone therapy (HT) with dose‐escalated external‐beam radiotherapy (DE‐EBRT) in the treatment of intermediate‐risk prostate cancer…”
Get full text